These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 12753310)
1. Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis. Iodice C; Balletta MM; Minutolo R; Giannattasio P; Tuccillo S; Bellizzi V; D'Amora M; Rinaldi G; Signoriello G; Conte G; De Nicola L Kidney Int; 2003 Jun; 63(6):2214-21. PubMed ID: 12753310 [TBL] [Abstract][Full Text] [Related]
2. Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease. Song JH; Cha SH; Lee HJ; Lee SW; Park GH; Lee SW; Kim MJ Nephrol Dial Transplant; 2006 Mar; 21(3):683-9. PubMed ID: 16330466 [TBL] [Abstract][Full Text] [Related]
3. Individual titration for maximal blockade of the renin-angiotensin system in proteinuric patients: a feasible strategy? Vogt L; Navis G; de Zeeuw D J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S53-7. PubMed ID: 15938035 [TBL] [Abstract][Full Text] [Related]
4. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation. Tylicki L; Rutkowski P; Renke M; Rutkowski B Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868 [TBL] [Abstract][Full Text] [Related]
5. Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial. Ruggiero B; Trillini M; Tartaglione L; Rotondi S; Perticucci E; Tripepi R; Aparicio C; Lecchi V; Perna A; Peraro F; Villa D; Ferrari S; Cannata A; Mazzaferro S; Mallamaci F; Zoccali C; Bellasi A; Cozzolino M; Remuzzi G; Ruggenenti P; Kohan DE; Am J Kidney Dis; 2019 Sep; 74(3):338-350. PubMed ID: 31027883 [TBL] [Abstract][Full Text] [Related]
7. Dual blockade of the rennin-angiotensin system versus maximal recommended dose of angiotensin II receptor blockade in chronic glomerulonephritis. Mori-Takeyama U; Minatoguchi S; Murata I; Fujiwara H; Ozaki Y; Ohno M; Oda H; Ohashi H Clin Exp Nephrol; 2008 Feb; 12(1):33-40. PubMed ID: 18175062 [TBL] [Abstract][Full Text] [Related]
8. Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial. Ferraro PM; Ferraccioli GF; Gambaro G; Fulignati P; Costanzi S Nephrol Dial Transplant; 2009 Jan; 24(1):156-60. PubMed ID: 18685141 [TBL] [Abstract][Full Text] [Related]
9. The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin. Perico N; Remuzzi A; Sangalli F; Azzollini N; Mister M; Ruggenenti P; Remuzzi G J Am Soc Nephrol; 1998 Dec; 9(12):2308-17. PubMed ID: 9848785 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Wühl E; Mehls O; Schaefer F; Kidney Int; 2004 Aug; 66(2):768-76. PubMed ID: 15253732 [TBL] [Abstract][Full Text] [Related]
11. Renin-angiotensin system inhibitors reduce the progression of mesangioproliferative glomerulonephritis: 10 year follow-up. Presta P; Minutolo R; Iodice C; Comi N; Casoria V; Fuiano L; Caglioti C; Conte G; Fuiano G Eur J Intern Med; 2011 Dec; 22(6):e90-4. PubMed ID: 22075320 [TBL] [Abstract][Full Text] [Related]
12. Reduction of proteinuria; combined effects of receptor blockade and low dose angiotensin-converting enzyme inhibition. Berger ED; Bader BD; Ebert C; Risler T; Erley CM J Hypertens; 2002 Apr; 20(4):739-43. PubMed ID: 11910311 [TBL] [Abstract][Full Text] [Related]
13. Dual renin-angiotensin system blockade at optimal doses for proteinuria. Laverman GD; Navis G; Henning RH; de Jong PE; de Zeeuw D Kidney Int; 2002 Sep; 62(3):1020-5. PubMed ID: 12164886 [TBL] [Abstract][Full Text] [Related]
14. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients. Renke M; Tylicki L; Rutkowski P; Wojnarowski K; Lysiak-Szydlowska W; Rutkowski B Scand J Urol Nephrol; 2005; 39(6):511-7. PubMed ID: 16303729 [TBL] [Abstract][Full Text] [Related]
15. Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies. Campbell R; Sangalli F; Perticucci E; Aros C; Viscarra C; Perna A; Remuzzi A; Bertocchi F; Fagiani L; Remuzzi G; Ruggenenti P Kidney Int; 2003 Mar; 63(3):1094-103. PubMed ID: 12631093 [TBL] [Abstract][Full Text] [Related]
16. Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis. Rutkowski P; Tylicki L; Renke M; Korejwo G; Zdrojewski Z; Rutkowski B Am J Kidney Dis; 2004 Feb; 43(2):260-8. PubMed ID: 14750091 [TBL] [Abstract][Full Text] [Related]
17. Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade. Ferrari P; Marti HP; Pfister M; Frey FJ J Hypertens; 2002 Jan; 20(1):125-30. PubMed ID: 11791035 [TBL] [Abstract][Full Text] [Related]
18. Effect of high dose ramipril with or without indomethacin on glomerular selectivity. Pisoni R; Ruggenenti P; Sangalli F; Lepre MS; Remuzzi A; Remuzzi G Kidney Int; 2002 Sep; 62(3):1010-9. PubMed ID: 12164885 [TBL] [Abstract][Full Text] [Related]
19. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker. O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081 [TBL] [Abstract][Full Text] [Related]
20. Effect of ramipril on blood pressure and protein excretion rate in normotensive nondiabetic patients with proteinuria. Toto RD; Adams-Huet B; Fenves AZ; Mitchell HC; Mulcahy W; Smith RD Am J Kidney Dis; 1996 Dec; 28(6):832-40. PubMed ID: 8957034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]